港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MIRXES-B

30.000

+6.70028.76%

成交量：917.87萬

成交額：2.75億

市值：82.90億

市盈率：- -

高：31.950

開：29.000

低：29.000

收：23.300

資料載入中...

總覽公司新聞公告

IPO週報|覓瑞登陸港交所；52TOYS成又一赴港上市的IP玩具公司

醫健IPO解碼丨覓瑞登陸港交所，“滴血驗癌”故事能否持續撐起82億港元市值？

21世纪经济报道

覓瑞MIRXES-B於港交所主板成功上市，畢馬威作為其申報會計師提供專業服務

港股綜述｜恆瑞醫藥首日飆漲25%，Mirxes漲28%；阿里影業漲超8%，港股三大股指衝高回落

老虎资讯综合

MIRXES-B(02629)首掛收報30港元較招股價高28.76%

《新股》MIRXES-B(02629.HK)全日收30元高上市價28.8%

阿斯达克财经

港股收盤，恒指收漲0.24%，科指收跌0.09%。上市首日，Mirxes-B(02629.HK)收漲28.76%，恆瑞醫

新加坡生物科技公司覓瑞集團在港上市

【IPO追蹤】股價一度飆37%！MIRXES上市首日表現強勁

港股午評：恒指漲0.58%科指漲0.61%！恆瑞醫藥漲超30%，MIRXES漲28%，嗶哩嗶哩漲5%，美團、網易、百度漲超1%

港股午評：新股表現亮眼恆瑞醫藥漲超30%

《新股》MIRXES-B(02629.HK)半日收29.8元高上市價27.9%

阿斯达克财经

祝賀！IVD企業敲鐘上市，市值超80億！

Mirxes覓瑞港股上市：募資淨額8.8億港元高榕創投是早期股東

剛剛，他靠一管血驗癌IPO了

招銀國際助力Mirxes Holding Company Limited首次成功公開發行並在香港聯交所主板掛牌上市

前淘寶總裁收穫一個IPO！Mirxes覓瑞登陸港交所開盤漲27%，市值82億港元

《股市簡訊》新加坡生物技術公司Mirxes香港“首秀”，盤初飆漲37%

MIRXES-B首掛上市股價現漲超30%

港股生物醫藥板塊狂飆，新股恆瑞醫藥、MIRXES均漲超30%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02629/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":30,"timestamp":1747987708030,"preClose":23.3,"halted":0,"volume":9178741,"delay":0,"floatShares":276342331,"shares":276342331,"eps":0,"marketStatus":"未開盤","change":6.7,"latestTime":"05-23 16:08:28","open":29,"high":31.95,"low":29,"amount":274942915,"amplitude":0.126609,"askPrice":30.05,"askSize":300,"bidPrice":30,"bidSize":9400,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748223000000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":23.3,"openAndCloseTimeList":[[1747963800000,1747972800000],[1747976400000,1747987200000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276342331,"roa":"-51.53%","roe":"--","lyrEps":0,"shares":276342331,"dividePrice":0,"high":31.95,"amplitude":0.126609,"preClose":23.3,"low":29,"week52Low":29,"pbRate":"-5.07","psRate":"52.18","week52High":31.95,"institutionHeld":0,"latestPrice":30,"committee":0.938144,"eps":0,"divideRate":0,"volume":9178741,"delay":0,"ttmEps":0,"open":29,"prevYearClose":23.3,"prevWeekClose":23.3,"prevMonthClose":23.3,"prevQuarterClose":23.3,"fiveDayClose":23.3,"twentyDayClose":23.3,"sixtyDayClose":23.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538110678","title":"IPO週報|覓瑞登陸港交所；52TOYS成又一赴港上市的IP玩具公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2538110678","media":"IPO早知道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538110678?lang=zh_tw&edition=fundamental","pubTime":"2025-05-25 22:09","pubTimestamp":1748182182,"startTime":"0","endTime":"0","summary":"觅瑞本次总计发行46,620,000股股份。手回集团计划在本次IPO中发行24,358,400股股份。这意味着，52TOYS成为受市场热捧的泡泡玛特、布鲁可后，又一家赴港上市的IP玩具公司。52TOYS品牌创立于2015年，目前主要提供静态玩偶、可动玩偶、发条玩具、变形机甲及拼装玩具、毛绒玩具及衍生周边等多品类IP玩具产品。根据灼识咨询报告，按2024年中国GMV计算，52TOYS是中国第二大多品类IP玩具公司。2022至2024年，52TOYS收入由4.6亿元增至6.3亿元，复合年增长率达16.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525221516a6ec66d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525221516a6ec66d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02621","02629"],"gpt_icon":1},{"id":"2537139092","title":"醫健IPO解碼丨覓瑞登陸港交所，“滴血驗癌”故事能否持續撐起82億港元市值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537139092","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537139092?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 20:12","pubTimestamp":1748002320,"startTime":"0","endTime":"0","summary":"截至23日收盘，这家miRNA明星公司每股报30.00港元，较发行价23.30港元大涨28.76%，总市值约82.90亿港元。觅瑞本次IPO全球发售4662万股，占发行完成后总股份的16.87%，每股定价23.30港元，募集资金总额约10.86亿港元，所得款净额约8.81亿港元。值得注意的是，觅瑞本次招股公开发售部分获25.51倍认购，国际发售部分获0.98倍认购。根据弗若斯特沙利文的资料，觅瑞是首家在基于血液的miRNA诊断检测领域及胃癌分子诊断检测领域获得FDA突破性医疗器械称号的公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-05-23/doc-inexqhfw5894956.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-23/doc-inexqhfw5894956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":1},{"id":"2537380611","title":"覓瑞MIRXES-B於港交所主板成功上市，畢馬威作為其申報會計師提供專業服務","url":"https://stock-news.laohu8.com/highlight/detail?id=2537380611","media":"毕马威KPMG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537380611?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 18:34","pubTimestamp":1747996440,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited于2025年5月23日在香港联合交易所主板完成首次公开发行并上市。毕马威作为觅瑞MIRXES-B上市的申报会计师参与该上市项目，提供专业服务。关于觅瑞MIRXES-B觅瑞MIRXES-B是一家总部位于新加坡的微小核糖核酸技术公司，致力于在亚洲关键市场提供疾病筛查诊断解决方案，提供用于癌症及其他疾病早期检测的基于血液的miRNA检测试剂盒。毕马威国际及其关联实体不提供任何客户服务。毕马威的名称和标识均属于毕马威国际的商标或注册商标。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-05-23/doc-inexpzxx0698661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"1100549993","title":"港股綜述｜恆瑞醫藥首日飆漲25%，Mirxes漲28%；阿里影業漲超8%，港股三大股指衝高回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1100549993","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100549993?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:42","pubTimestamp":1747989772,"startTime":"0","endTime":"0","summary":"个股方面：“A+H药企龙头”恒瑞医药、“新加坡微小核糖核酸技术公司”Mirxes两只新股今日登陆港交所，分别收涨25.2%、28.76%。$中国卫生集团$今日复牌一度飙升超1.7倍，最终收涨110.71%，公司折让28.6%配股引入新投资者。阿里影业涨超8%，公司拟更名为大麦娱乐，$花旗$称IP商品潜力尚未完全释放。A股行情A股市场冲高回落，三大指数午后集体跳水。截至收盘，沪指跌0.94%报3348点，深证成指跌0.85%，创业板指跌1.18%。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","02629","01276","01060"],"gpt_icon":1},{"id":"2537618511","title":"MIRXES-B(02629)首掛收報30港元 較招股價高28.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537618511","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537618511?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:38","pubTimestamp":1747989480,"startTime":"0","endTime":"0","summary":"金吾财讯 | MIRXES-B(02629)首挂收报30港元，较招股价高28.76%，全日成交917.87万股，成交额2.75亿港元。不计手续费，每手100股，账面赚670港元。首挂开报29港元，亦为全日最低价，较招股价高24.46%，全日最高31.95港元。最新总市值82.9亿港元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2537188456","title":"《新股》MIRXES-B(02629.HK)全日收30元 高上市價28.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537188456","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537188456?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:15","pubTimestamp":1747988100,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 首日挂牌，开报29元，较上市价23.3元，高24.5%；最高/低分别见31.95/29元，全日收30元，较上市价23.3元，高28.8%，全日成交917.87万股，涉资2.74亿元。不计手续费，每手100股，账面赚670元。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142909241_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142909241_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1442045/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537188519","title":"港股收盤，恒指收漲0.24%，科指收跌0.09%。上市首日，Mirxes-B(02629.HK)收漲28.76%，恆瑞醫","url":"https://stock-news.laohu8.com/highlight/detail?id=2537188519","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537188519?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:09","pubTimestamp":1747987749,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2328871848.SGD","600276","BK0060","HSTECH","LU0405327494.USD","HSCEI","HHImain","BK0188","YANG","LU1064131003.USD","BK0196","BK0239","LU0405327148.USD","513600","MCHmain","BK0183","07226","LU1328615791.USD","HSI","LU2148510915.USD","LU1969619763.USD","01276","MHImain","LU2488822045.USD","BK0028","02833","BK0012","BK4614","HSImain","LU1064130708.USD","02629"],"gpt_icon":0},{"id":"2537904786","title":"新加坡生物科技公司覓瑞集團在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2537904786","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537904786?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 14:37","pubTimestamp":1747982221,"startTime":"0","endTime":"0","summary":"新华财经香港5月23日电觅瑞集团（MIRXES-B，02629）23日在香港交易所主板上市，中金公司、建银国际为其联席保荐人。MIRXES-B每股发行价23.3港元，共发行4662万股股份，每手100股，所得款项净额约8.81亿港元。截至午市休盘，MIRXES-B上涨27.90%，报29.80港元，市值超82.35亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505233413051755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02629"],"gpt_icon":1},{"id":"2537902935","title":"【IPO追蹤】股價一度飆37%！MIRXES上市首日表現強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2537902935","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537902935?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 14:24","pubTimestamp":1747981492,"startTime":"0","endTime":"0","summary":"5月23日，港股市场又迎来两只医药股上市，包括恒瑞医药（600276.SH，01276.HK）、MIRXES-B（02629.HK）。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202505_1/1f92df6e-4d8f-4e00-a46c-27da160e6b69.PNG","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202505_1/1f92df6e-4d8f-4e00-a46c-27da160e6b69.PNG"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/683014b45a7712a46968709d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02629"],"gpt_icon":1},{"id":"2537190579","title":"港股午評：恒指漲0.58%科指漲0.61%！恆瑞醫藥漲超30%，MIRXES漲28%，嗶哩嗶哩漲5%，美團、網易、百度漲超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537190579","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537190579?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 12:38","pubTimestamp":1747975099,"startTime":"0","endTime":"0","summary":"截至午间收盘，恒生指数涨0.58%，报23679.99点，恒生科技指数涨0.61%，国企指数涨0.75%。盘面上，科网股全线上涨，哔哩哔哩涨超5%，美团、网易、百度集团涨超1%；生物医药板块狂飙，新股恒瑞医药、MIRXES分别涨超30%、28%；影视股齐涨，阿里影业涨超11%。生物医药板块狂飙，新股恒瑞医药、MIRXES分别涨超30%、27%。近日，阿里大文娱集团宣布即日起更名为虎鲸文娱集团，旗下阿里影业拟更名为大麦娱乐。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523124040a6e9bb37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523124040a6e9bb37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0183","01276","BK0060","LU1328615791.USD","LU2148510915.USD","02629","LU0405327148.USD","LU2328871848.SGD","BK0028","600276","BK0196","BK0239","LU1064130708.USD","BK0012","01060","LU1064131003.USD","LU1969619763.USD","LU2488822045.USD","LU0405327494.USD","BK0188"],"gpt_icon":0},{"id":"2537590303","title":"港股午評：新股表現亮眼 恆瑞醫藥漲超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537590303","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537590303?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 12:05","pubTimestamp":1747973109,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["HHImain","02629","BABA","HSImain","MCHmain","LU1328277881.USD","01276","HSTECH","LU0043850808.USD","600276","159562","06127","06110","513600","01211","002594","09988","HSI","02833","HYDD.SI","603127","LU0823039010.USD","09886","LU0396098781.USD","00673","LU2249611893.SGD","LU0979878070.USD","01929","MHImain","ALBmain","00302","BILI","HSCEI","HBBD.SI","LU1048588211.SGD","LU0831103253.SGD","BYDDY","00772","81211","BK1579","LU1282651121.HKD","BK1502","09626","SG9999015945.SGD","01060","07226","LU0228367735.SGD","LU0048597586.USD","89988","YANG"],"gpt_icon":0},{"id":"2537903070","title":"《新股》MIRXES-B(02629.HK)半日收29.8元 高上市價27.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903070","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903070?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 12:05","pubTimestamp":1747973100,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 首日挂牌，开报29元，较上市价23.3元，高24.5%。最高/低分别见31.95/29元，半日收29.8元，较上市价23.3元，高27.9%，半日成交714.95万股，涉资2.13亿元。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190215132747632_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190215132747632_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441970/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537900040","title":"祝賀！IVD企業敲鐘上市，市值超80億！","url":"https://stock-news.laohu8.com/highlight/detail?id=2537900040","media":"IVD资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537900040?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 11:34","pubTimestamp":1747971278,"startTime":"0","endTime":"0","summary":"来源：IVD资讯综合高榕创投、觅瑞招股书5月23日，Mirxes觅瑞正式在香港联合交易所主板挂牌上市，每股发行价为23.30港元，开盘后市值超80亿港元！祝贺觅瑞成功敲钟上市，也给了这几年资本市场不振的IVD行业以信心和动力！公司的核心产品GASTROClear为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。全球大规模化的临床试验和药监认证，为Mirxes觅瑞未来在大范围内的产品推广和技术应用提供了有力保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523155157a6e9ee91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523155157a6e9ee91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":1},{"id":"2537903834","title":"Mirxes覓瑞港股上市：募資淨額8.8億港元 高榕創投是早期股東","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903834","media":"雷递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903834?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 11:31","pubTimestamp":1747971101,"startTime":"0","endTime":"0","summary":"雷递网 乐天 5月23日Mirxes觅瑞今日在港交所上市，发行价为23.3港元。发行4662万股，募资总额为10.86亿港元，扣除发行上市费用2.06亿港元，募资净额为8.81亿港元。Mirxes觅瑞致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。2023年，Mirxes觅瑞在中国完成了9,472例受试者的注册临床试验，已向中国国家药品监督管理局提交了注册，有望在获批上市后为中国市场带来增长。高榕创投曾于2018年投资Mirxes觅瑞，是公司最早的机构股东，并长期陪伴公司发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523113735a6e9ac96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523113735a6e9ac96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","HSCEI","02629"],"gpt_icon":1},{"id":"2537857970","title":"剛剛，他靠一管血驗癌IPO了","url":"https://stock-news.laohu8.com/highlight/detail?id=2537857970","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537857970?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 10:37","pubTimestamp":1747967849,"startTime":"0","endTime":"0","summary":"一管血就能验癌的公司，成功上市了。按照弗若斯特沙利文的说法，作为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组，GASTROClear为全球首款也是唯一一款获批准进行胃癌筛查的分子诊断IVD产品。一管血验癌，年入上亿元作为一家miRNA公司，Mirxes觅瑞目前拥有三种已商业化产品和六种处于临床前阶段的候选产品。其中，液体活检能通过检测血液及尿液等液体样本，寻找miRNA等癌症生物标志物，从而判断患者是否患癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231038459762ae0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231038459762ae0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":1},{"id":"2537970274","title":"招銀國際助力Mirxes Holding Company Limited首次成功公開發行並在香港聯交所主板掛牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2537970274","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537970274?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 10:04","pubTimestamp":1747965896,"startTime":"0","endTime":"0","summary":"交易概述2025年5月23日，Mirxes Holding Company Limited成功于香港联合交易所主板挂牌上市。招银国际担任 Mirxes 在香港首次公开发行的联席账簿管理人及联席牵头经办人，助力Mirxes成功发行上市。Mirxes此次全球发行46,620,000股，发行价格为每股23.30港元，总募资金额约10.86亿港元。招银国际作为本次项目的联席账簿管理人及联席牵头经办人，充分发挥了在资本市场中的专业优势，为Mirxes的成功上市提供了全方位支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523105258a6e9a188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523105258a6e9a188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":0},{"id":"2537972926","title":"前淘寶總裁收穫一個IPO！Mirxes覓瑞登陸港交所開盤漲27%，市值82億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537972926","media":"地产k线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537972926?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 09:45","pubTimestamp":1747964715,"startTime":"0","endTime":"0","summary":"乐居财经 吴文婷5月23日，觅瑞MIRXES-B在港交所挂牌上市，中金公司、建银国际联席保荐。其开盘报29.6港元，涨27%，总市值约81.8亿港元。据招股书，2022年-2024年，觅瑞实现收益分别为1775.9万美元、2418.5万美元、2028.27万美元；年内亏损分别为5620.27万美元、6956.93万美元、9221.47万美元。IPO前，前淘宝CEO孙彤宇全资拥有的Central Road持股22.03%，为觅瑞的第一大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523094955a488f33b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523094955a488f33b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU1770034418.SGD","LU0128522744.USD","LU0871576103.HKD","LU0359201612.USD","IE00BMPRXR70.SGD","HBBD.SI","LU0898667661.SGD","LU0396098781.USD","LU1720051108.HKD","LU0572940350.SGD","LU2039709279.SGD","LU0173614495.USD","LU0287142896.SGD","LU0648948544.HKD","SG9999014674.SGD","LU0543330483.HKD","ALBmain","LU1044875133.USD","LU0650527681.SGD","LU0348783233.USD","LU0054450605.USD","02629","LU1993786604.SGD","LU0214875030.USD","BK1618","LU0577902611.USD","LU1051768304.USD","LU0106959298.USD","LU0164880469.USD","LU0516423174.USD","LU0531970944.HKD","LU0164865239.USD","LU1303224171.USD","LU0589944569.HKD","LU0348825331.USD","LU1548497426.USD","LU0455707207.USD","LU0593848301.USD","BK1575","LU2097828557.USD","SG9999000327.SGD","LU1282651121.HKD","89988","LU0011963245.USD","BK1502","LU0588545904.SGD","LU1366334651.USD"],"gpt_icon":0},{"id":"2537971001","title":"《股市簡訊》新加坡生物技術公司Mirxes香港“首秀”，盤初飆漲37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537971001","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537971001?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 09:38","pubTimestamp":1747964302,"startTime":"0","endTime":"0","summary":"《股市简讯》新加坡生物技术公司Mirxes香港“首秀”，盘初飙涨37%* 总部位于新加坡的微小核糖核酸技术公司--Mirxes2629.HK周五香港首日挂牌，盘初较招股价飙涨37%，触及31.95港元。* 该公司按招股价每股23.3港元发售4,662万股股份，集资10.86亿港元，上市市值64亿港元；香港公开发售和国际配售分别获25.5倍及0.98倍认购。* 香港股市恒生指数.HSI盘初跌0.1%，恒生香港上市生物科技指数.HSHKBIO涨1.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4S3RV03Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","00656","02629"],"gpt_icon":1},{"id":"2537974427","title":"MIRXES-B首掛上市 股價現漲超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537974427","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537974427?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 09:38","pubTimestamp":1747964280,"startTime":"0","endTime":"0","summary":"　　MIRXES-B首挂上市，公告显示，每股定价23.3港元，共发行4662万股股份，每手100股，所得款项净额约8.81亿港元。截至发稿，股价上涨30.47%，现报30.40港元，成交额1.20亿港元。　　公开资料显示，Mirxes成立于2014年，公司是一家总部位于新加坡的微小核糖核酸技术公司，致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。截至最后实际可行日期，集团拥有一种核心产品、两种其他商业化产品及六种处于临床前阶段的候选产品。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-05-23/doc-inexpeuk6281354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"2537742369","title":"港股生物醫藥板塊狂飆，新股恆瑞醫藥、MIRXES均漲超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742369","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537742369?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 09:35","pubTimestamp":1747964100,"startTime":"0","endTime":"0","summary":"5月23日消息，港股生物技术、药品股多股大涨，其中，今日正式上市的恒瑞医药和MIRXES分别涨超30%、36%。歌礼制药、博安生物、科伦博泰生物、凯莱英、信达生物等个股纷纷大涨。　　个股方面，恒瑞医药在公开发售阶段获454.85倍认购，国际配售阶段获17.09倍认购。据恒瑞医药披露的2024年年度报告，2024年公司实现营业收入279.85亿元，同比增长22.63%；归属于上市公司股东的净利润63.37亿元，同比增长47.28%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-05-23/doc-inexpeui1008253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2328871848.SGD","HSCEI","LU0405327148.USD","BK0028","BK0060","BK0188","YANG","LU1064131003.USD","BK4614","07226","399441","LU2488822045.USD","BK0239","02629","01276","HSTECH","BK0196","LU1064130708.USD","BK0012","600276","LU2148510915.USD","BK0183","LU1969619763.USD","LU1328615791.USD","LU0405327494.USD","161726"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{}}}